Obbligazione European Investment Bank (EIB) 1.375% ( US298785JQ02 ) in USD

European Investment Bank (EIB)

94.89 USD ▲

Lussemburgo

US298785JQ02 ( in USD )

1.375% per anno ( pagato 2 volte l'anno)

14/03/2027

Prospetto opuscolo dell'obbligazione European Investment Bank (EIB) US298785JQ02 en USD 1.375%, scadenza 14/03/2027

298785JQ0

15/03/2025 ( Domani )

La Banca Europea per gli Investimenti (BEI) è l'istituzione finanziaria dell'Unione europea che fornisce finanziamenti a lungo termine per progetti di investimento in tutta Europa e nei paesi in via di sviluppo.

The Obbligazione issued by European Investment Bank (EIB) ( Luxembourg ) , in USD, with the ISIN code US298785JQ02, pays a coupon of 1.375% per year.
The coupons are paid 2 times per year and the Obbligazione maturity is 14/03/2027

Filed pursuant to Rule 424(b)(5)
Registration No. 333-251291
PROSPECTUS SUPPLEMENT

(To Prospectus dated December 23, 2020)
European Investment Bank
$5,000,000,000 1.375% Notes due 2027
The 1.375% notes due 2027 offered hereby (the "Notes") will bear interest at a rate of 1.375% per year. The European Investment Bank (the "EIB") will pay interest on the Notes on
March 15 and September 15 of each year, commencing on March 15, 2022 (short first coupon for the period from, and including, January 12, 2022 to, but excluding, March 15, 2022).
The Notes will mature on March 15, 2027. The EIB will not have the right to redeem the Notes before their scheduled maturity. The Notes will be unconditional, direct and general
obligations of the EIB in accordance with the terms for their payment and performance. The Notes will rank pari passu with any present or future indebtedness of the EIB represented by
any unsubordinated and unsecured notes or bonds.
Application has been made for the Notes to be listed on the Official List of the Luxembourg Stock Exchange and admitted to trading on the Bourse de Luxembourg, which is the
regulated market of the Luxembourg Stock Exchange. No assurance can be given that such application will be approved or that any of the Notes will be listed and admitted to trading
thereon, and settlement of the Notes is not conditioned on obtaining this listing.
PRICE OF THE NOTES 99.539%

Per Note

Total
Public offering price (1)

99.539 %
$4,976,950,000
Underwriting discount

0.125 %
$6,250,000
Proceeds, before expenses, to the EIB (1)

99.414 %
$4,970,700,000
(1) Plus accrued interest, if any, from January 12, 2022 if settlement occurs after that date.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the Notes or determined if this prospectus supplement or
the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The underwriters named in this prospectus supplement expect to deliver the Notes to purchasers in book-entry form only, through the facilities of The Depository Trust Company
("DTC") for the accounts of its direct and indirect participants (including Euroclear Bank SA/NV ("Euroclear") and Clearstream Banking S.A. ("Clearstream")) on or about January 12,
2022.

BARCLAYS
CITIBANK
DEUTSCHE BANK

The date of this prospectus supplement is January 5, 2022.

TABLE OF CONTENTS
Prospectus Supplement

Prospectus

Page

Page
About this Prospectus Supplement
S-3

About this Prospectus
3
Where You Can Find More Information
S-4

Where You Can Find More Information
4
Incorporation by Reference
S-5

Incorporation by Reference
4
Forward-Looking Statements
S-8

Forward-Looking Statements
7
Summary of the Offering
S-9

The European Investment Bank
8
Use of Proceeds
S-11
Use of Proceeds
13
Description of Notes
S-12
Description of Securities
14
Underwriters
S-16
Book-Entry, Delivery and Form
21
Validity of the Notes
S-22
Plan of Distribution
26
Experts
S-22
Currency Conversions and Foreign Exchange Risks
27
General Information
S-23
Taxation
29
Official Statement
S-23
Validity of the Securities
36

Experts
36

Enforceability of Civil Liabilities
37

Authorized Representative in the United States
38

Official Statement
38
S-2

ABOUT THIS PROSPECTUS SUPPLEMENT
This document consists of two parts. The first part is this prospectus supplement, which describes the specific terms of this offering and the Notes being offered. This prospectus
supplement may also add, update or change information contained in the accompanying prospectus. The second part, the accompanying prospectus, presents general information
about us and a general description of the debt securities we may offer from time to time, some of which does not apply to the Notes being offered. If the information in this prospectus
supplement differs from the information contained in the accompanying prospectus, you should rely on the information in this prospectus supplement. If we use a capitalized term in
this prospectus supplement and do not define the term in this document, it is defined in the accompanying prospectus.
You should read both this prospectus supplement and the accompanying prospectus together with additional information described under the headings "Where You Can Find More
Information" and "Incorporation by Reference" below before you purchase the Notes. We have not authorized anyone to provide you with information different from that contained or
incorporated by reference in this prospectus supplement and the accompanying prospectus or any "free writing prospectus" prepared by or on behalf of us. We take no responsibility
for, and can provide no assurance as to the reliability of, any other information that others may give you.
You should not assume that the information in this prospectus supplement, the accompanying prospectus or any document incorporated by reference therein is accurate or
complete at any date other than the date indicated on the cover page of those documents. Our business, financial condition, results of operations and prospects may have changed
since those dates.
We are not offering to sell the Notes or soliciting offers to purchase the Notes in any jurisdiction where the offer or sale is not permitted. The Notes are offered globally for sale in
those jurisdictions in the United States, Canada, Europe, Asia and elsewhere where it is lawful to make such offers. The distribution of this prospectus supplement and the
accompanying prospectus and the offering of the Notes in certain jurisdictions may be restricted by law. Persons into whose possession this prospectus supplement and the
accompanying prospectus come should inform themselves about and observe any such restrictions. This prospectus supplement and the accompanying prospectus do not constitute,
and may not be used in connection with, an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not authorized or in which the person making such
offer or solicitation is not qualified to do so or to any person to whom it is unlawful to make such offer or solicitation. See "Underwriters--Selling Restrictions".
While application has been made for the Notes to be listed on the Official List of the Luxembourg Stock Exchange and admitted to trading on the Bourse de Luxembourg, which is
the regulated market of the Luxembourg Stock Exchange, we cannot guarantee that such application will be approved or that any of the Notes will be listed and admitted to trading
thereon, and settlement of the Notes is not conditioned on obtaining this listing. See "Description of Notes--Listing".
References in this prospectus supplement to "we", "our" or "us" are to the EIB. References to "U.S. dollars", "USD", "U.S. $", "dollar" or "$" are to the lawful currency of the
United States.
S-3

WHERE YOU CAN FIND MORE INFORMATION
The registration statement of which this prospectus supplement and the accompanying prospectus form part, including the attached exhibits and schedules, contains additional
relevant information about the Notes. The rules and regulations of the SEC allow us to omit certain information included in the registration statement from this prospectus supplement
and the accompanying prospectus.
While the EIB is not subject to the periodic reporting requirements of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act"), we file reports and other
information with the SEC under the Exchange Act on a voluntary basis. The SEC maintains an internet site that contains reports, proxy and information statements, and other
information regarding issuers that file electronically with the SEC (http://www.sec.gov), on which all our filings made after December 15, 2002 are available.
This prospectus supplement and the accompanying prospectus will be published on the official website of the Luxembourg Stock Exchange (http://www.bourse.lu). Information
available on this website is not, and shall not be deemed to be, part of or incorporated by reference into this prospectus supplement.
S-4

INCORPORATION BY REFERENCE
The SEC allows us to "incorporate by reference" into this prospectus supplement and the accompanying prospectus the information we file with the SEC, which means that:

we can disclose important information to you by referring you to another document filed separately with the SEC

information in a document incorporated by reference in this prospectus supplement is considered to be a part of this prospectus supplement and the accompanying
prospectus

information in this prospectus supplement automatically updates and supersedes information in earlier documents that are incorporated by reference in this prospectus
supplement and the accompanying prospectus

information in a document incorporated by reference in this prospectus supplement automatically updates and supersedes information in earlier documents that are
incorporated by reference in this prospectus supplement and the accompanying prospectus and

information that we file in the future with the SEC that we incorporate by reference in this prospectus supplement will automatically update and supersede information in
this prospectus supplement and the accompanying prospectus.
This prospectus supplement incorporates by reference the documents listed below that the EIB previously filed with the SEC. They contain important information about us. All
other documents which the EIB previously filed with the SEC, including those listed under the heading "Incorporation by Reference" in the accompanying prospectus, have been
superseded by the documents listed below.
SEC Filings

Annual Reports on Form 18-K

For the fiscal year ended December 31, 2020, as filed with the SEC on May 3, 2021 (File No. 001-05001)

For the fiscal year ended December 31, 2019, as filed with the SEC on May 5, 2020 (File No. 001-05001)
Amendments on Form 18-K/A

Amendment No. 1 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2020, as filed with the
SEC on May 13, 2021 (File No. 001-05001)

Amendment No. 3 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2020, as filed with the
SEC on August 9, 2021 (File No. 001-05001)

Amendment No. 4 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2020, as filed with the
SEC on September 1, 2021 (File No. 001-05001)

Amendment No. 1 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on May 19, 2020 (File No. 001-05001)

Amendment No. 2 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on June 9, 2020 (File No. 001-05001)
S-5

Amendment No. 4 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on August 10, 2020 (File No. 001-05001)

Amendment No. 5 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on August 10, 2020 (File No. 001-05001)

Amendment No. 6 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on September 16, 2020 (File No. 001-05001)

Amendment No. 7 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on September 23, 2020 (File No. 001-05001)

Amendment No. 8 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on October 21, 2020 (File No. 001-05001)

Amendment No. 9 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on November 6, 2020 (File No. 001-05001)

Amendment No. 10 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on December 11, 2020 (File No. 001-05001)

Amendment No. 11 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on December 23, 2020 (File No. 001-05001)

Amendment No. 12 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on January 12, 2021 (File No. 001-05001)

Amendment No. 13 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on February 16, 2021 (File No. 001-05001)

Amendment No. 14 to the Annual Report on Form 18-K/A for the fiscal year ended December 31, 2019, as filed with the
SEC on April 27, 2021 (File No. 001-05001)
S-6

The EIB also incorporates by reference in this prospectus supplement any future filings, or portions of such filings, made with the SEC under the Exchange Act, after the date of this
prospectus supplement until completion of this offering, to the extent such filings, or such portions of such filings, indicate that they are intended to be incorporated by reference in this
prospectus supplement.
Upon written or oral request, we will provide to any person, including any beneficial owner, to whom a copy of this prospectus supplement is delivered, at no cost to such person, a
copy of any or all of the information that has been incorporated by reference in this prospectus supplement but not delivered with this prospectus supplement. You may make such a
request by writing or telephoning us at the following address or telephone number:
European Investment Bank
Capital Markets Department
98-100, boulevard Konrad Adenauer
L-2950 Luxembourg
Grand Duchy of Luxembourg
Telephone: (+352) 43 79 1
E-mail: [email protected]
S-7

FORWARD-LOOKING STATEMENTS
This prospectus supplement and the accompanying prospectus and documents incorporated by reference in this prospectus supplement and the accompanying prospectus may
contain forward-looking statements. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements.
Forward-looking statements involve inherent risks, uncertainties and other factors that may cause our actual results, performance or achievements to differ materially from the
anticipated results, performance or achievements expressed or implied in these forward-looking statements. Although we believe that the expectations reflected in such forward-looking
statements and forecasts are reasonable, no assurance can be given that such expectations will prove to have been correct. Accordingly, actual results could differ materially from those
contained in any forward-looking statements. Consequently, you are cautioned not to place undue reliance on forward-looking statements.
Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update publicly or release any revisions to these forward-looking statements
in light of new information or to reflect events or circumstances after the date of the particular statement or to reflect the occurrence of unanticipated events, except to the extent required
by applicable law. All subsequent forward-looking statements attributable to us or any person acting on our behalf are qualified by the cautionary statements herein.
S-8

SUMMARY OF THE OFFERING
The following summary is qualified in its entirety by, and should be read in conjunction with, the more detailed information appearing elsewhere in this prospectus
supplement and the accompanying prospectus.

Issuer
European Investment Bank.

Securities Offered
$5,000,000,000 aggregate principal amount of 1.375% Notes due 2027.

Ranking
The Notes will be unconditional, direct and general obligations of the EIB in accordance with the terms for their
payment and performance. The Notes will rank pari passu with any present or future indebtedness of the EIB
represented by any unsubordinated and unsecured notes or bonds.

Maturity Date
March 15, 2027.

Interest Payment Dates
March 15 and September 15 of each year, commencing on March 15, 2022 (short first coupon for the period from,
and including, January 12, 2022 to, but excluding, March 15, 2022).

Record Dates
The close of business on March 5 and September 5 (whether or not a business day) prior to each Interest
Payment Date.

Interest Rate
1.375% per annum.

Denominations
The Notes will be issued in minimum denominations of $1,000 and integral multiples thereof.

Redemption
The Notes are not subject to redemption prior to their scheduled maturity.

Use of Proceeds
The net proceeds from the sale of the Notes will be used in the general operations of the EIB, including
disbursements of loans heretofore or hereafter granted by the EIB. See "Use of Proceeds".

Further Issues
The EIB may from time to time, without notice to or the consent of any of the holders of the Notes, create and
issue additional notes ranking pari passu with the Notes and having the same terms as to status, interest rate,
maturity, redemption or otherwise in all respects as the Notes (except for the public offering price, the issue
date, and in some cases, the first interest payment date). Such additional notes shall be consolidated and form a
single series with the Notes, including for purposes of voting and redemptions, and increase the aggregate
principal amount of the Notes. See "Description of Notes--Further Issues".

S-9

Governing Law
State of New York.

Markets
The Notes are offered for sale in those jurisdictions in the United States, Canada, Europe, Asia and elsewhere
where it is lawful to make such offers. See "Underwriters--Selling Restrictions".

Listing
Application has been made for the Notes to be listed on the Official List of the Luxembourg Stock Exchange and
admitted to trading on the Bourse de Luxembourg, which is the regulated market of the Luxembourg Stock
Exchange. No assurance can be given that such application will be approved or that any of the Notes will be
listed and admitted to trading thereon, and settlement of the Notes is not conditioned on obtaining this listing.
If the application is approved, the EIB will have no obligation to maintain such listing, and may delist the Notes
at any time.

Book-Entry Form, Settlement and Clearance
The Notes will be represented by the Global Note registered in the name of Cede & Co. as nominee for DTC.
The Global Note will be deposited with a custodian for DTC. Investors may elect to hold interests in the Global
Note through DTC, if they are participants in DTC, or indirectly through organizations that are participants in
DTC. Initial settlement for the Notes will be made in immediately available funds in U.S. dollars. See "Book-
Entry, Delivery and Form" in the accompanying prospectus.

Closing and Delivery
It is currently expected that delivery of the Notes will occur on or about January 12, 2022.

Withholding Tax
The EIB has been advised that under current U.S. tax law payments of principal of and interest on the Notes
may generally be made by the EIB without withholding or deduction for U.S. withholding taxes. For further
details, see "Taxation" in the accompanying prospectus.

Fiscal Agent, Registrar, Transfer Agent and Paying Agent
Citibank, N.A., London Branch.

Listing Agent
Banque Internationale à Luxembourg S.A.

S-10